Literature DB >> 15229104

Cardiac contractile dysfunction in J2N-k cardiomyopathic hamsters is associated with impaired SR function and regulation.

Andrea P Babick1, Elliott J F Cantor, John T Babick, Nobuakira Takeda, Naranjan S Dhalla, Thomas Netticadan.   

Abstract

Although dilated cardiomyopathy (DCM) is known to result in cardiac contractile dysfunction, the underlying mechanisms are unclear. The sarcoplasmic reticulum (SR) is the main regulator of intracellular Ca2+ required for cardiac contraction and relaxation. We therefore hypothesized that abnormalities in both SR function and regulation will contribute to cardiac contractile dysfunction of the J2N-k cardiomyopathic hamster, an appropriate model of DCM. Echocardiographic assessment indicated contractile dysfunction, because the ejection fraction, fractional shortening, cardiac output, and heart rate were all significantly reduced in J2N-k hamsters compared with controls. Depressed cardiac function was associated with decreased cardiac SR Ca2+ uptake in the cardiomyopathic hamsters. Reduced SR Ca2+ uptake could be further linked to a decrease in the expression of the SR Ca(2+)-ATPase and cAMP-dependent protein kinase (PKA)-mediated phospholamban (PLB) phosphorylation at serine-16. Depressed PLB phosphorylation was paralleled with a reduction in the activity of SR-associated PKA, as well as an elevation in protein phosphatase activity in J2N-k hamster. The results of this study suggest that an alteration in SR function and its regulation contribute to cardiac contractile dysfunction in the J2N-k cardiomyopathic hamster.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15229104     DOI: 10.1152/ajpcell.00155.2004

Source DB:  PubMed          Journal:  Am J Physiol Cell Physiol        ISSN: 0363-6143            Impact factor:   4.249


  7 in total

1.  High dietary sucrose triggers hyperinsulinemia, increases myocardial beta-oxidation, reduces glycolytic flux and delays post-ischemic contractile recovery.

Authors:  D Gonsolin; K Couturier; B Garait; S Rondel; V Novel-Chaté; S Peltier; P Faure; P Gachon; Y Boirie; C Keriel; R Favier; S Pepe; L Demaison; X Leverve
Journal:  Mol Cell Biochem       Date:  2006-08-31       Impact factor: 3.396

2.  No correlation between the p38 MAPK pathway and the contractile dysfunction in diabetic cardiomyocytes: hyperglycaemia-induced signalling and contractile function.

Authors:  Sibylle Wenzel; Golozar Soltanpour; Klaus-Dieter Schlüter
Journal:  Pflugers Arch       Date:  2005-07-23       Impact factor: 3.657

3.  Regulation of sarcoplasmic reticulum Ca2+ ATPase 2 (SERCA2) activity by phosphodiesterase 3A (PDE3A) in human myocardium: phosphorylation-dependent interaction of PDE3A1 with SERCA2.

Authors:  Faiyaz Ahmad; Weixing Shen; Fabrice Vandeput; Nicolas Szabo-Fresnais; Judith Krall; Eva Degerman; Frank Goetz; Enno Klussmann; Matthew Movsesian; Vincent Manganiello
Journal:  J Biol Chem       Date:  2015-01-15       Impact factor: 5.157

4.  Alterations in the expression of myocardial calcium cycling genes in rats fed a low protein diet in utero.

Authors:  Paramjit S Tappia; Heather Sandhu; Tina Abbi; Nina Aroutiounova
Journal:  Mol Cell Biochem       Date:  2008-12-23       Impact factor: 3.396

5.  δ-Sarcoglycan-deficient muscular dystrophy: from discovery to therapeutic approaches.

Authors:  Alison M Blain; Volker W Straub
Journal:  Skelet Muscle       Date:  2011-03-17       Impact factor: 4.912

6.  Longitudinal observations of progressive cardiac dysfunction in a cardiomyopathic animal model by self-gated cine imaging based on 11.7-T magnetic resonance imaging.

Authors:  Shigeyoshi Saito; Minori Tanoue; Kasumi Masuda; Yuki Mori; Satoshi Nakatani; Yoshichika Yoshioka; Kenya Murase
Journal:  Sci Rep       Date:  2017-08-22       Impact factor: 4.379

7.  TNF-alpha-mediated signal transduction pathway is a major determinant of apoptosis in dilated cardiomyopathy.

Authors:  Samarjit Das; Andrea P Babick; Yan-Jun Xu; Nobuakira Takeda; Delfin Rodriguez-Levya; Naranjan S Dhalla
Journal:  J Cell Mol Med       Date:  2009-09-14       Impact factor: 5.310

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.